Canagliflozin or acarbose versus placebo to ameliorate post-bariatric hypoglycaemia - The HypoBar I randomized clinical trial protocol.

Carolina B LobatoClara Tornoe WindingKirstine N Bojsen-MøllerChristoffer MartinussenSimon VeedfaldJens J HolstSten MadsbadNils Bruun JørgensenCarsten Dirksen

Published in: Diabetic medicine : a journal of the British Diabetic Association (2024)

EudraCT number 2022-000157-87.

Keyphrases

double blind
type diabetes
weight loss
randomized controlled trial
roux en y gastric bypass
phase iii
placebo controlled